StockNews.com Initiates Coverage on Avinger (NASDAQ:AVGR)

Research analysts at StockNews.com started coverage on shares of Avinger (NASDAQ:AVGR) in a report issued on Wednesday. The brokerage set a “hold” rating on the medical device company’s stock.

Avinger Price Performance

Shares of Avinger stock opened at $0.47 on Wednesday. Avinger has a 12 month low of $0.36 and a 12 month high of $4.37. The stock has a market capitalization of $1.57 million, a price-to-earnings ratio of -0.04 and a beta of 1.09. The firm’s fifty day simple moving average is $0.50 and its 200-day simple moving average is $0.74.

Avinger Company Profile

Avinger, Inc, a commercial-stage medical device company, designs, manufactures, and sells a suite of image-guided and catheter-based systems used by physicians to treat patients with peripheral artery disease (PAD) primarily in the United States and Germany. The company develops lumivascular platform that integrates optical coherence tomography visualization with interventional catheters to provide real-time intravascular imaging during the treatment portion of PAD procedures.